The World Bank will assist Georgia in the acquisition of expensive monoclonal antibodies.

“RONAPREVE medicine is the best option for "monoclonal antibodies". Its use has begun in several countries worldwide. Georgia will be one of the first to use it. Serious negotiations are underway, including with the World Bank, which has promised Georgia to help purchase this very expensive medicine. This medication will most likely flow in the second half of October. We will receive the first flow of this medication, most likely, in late October.

As for the second expensive drug, "Baricitinib", according to Tengiz Tsertsvadze, the drug will enter the country in late October and has antiviral and anti-inflammatory effects, which will significantly reduce the risk of a aggravation of symptoms in a patient.